Form D · Biotechnology
Hana Biosciences Inc
South San Francisco, CA · CIK 1140028
Offering snapshot reported Jun 18, 2010 · SEC filing
- Reported sold
- $37.5M Offering amount: $97.6M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 7, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 18, 2010 | Initial | $37,512,000 | No comparison | 4 | SEC filing |
| Oct 22, 2009 | Initial | $16,267,844 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $400K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-143754
Does not include $2,488,000 offered and sold to foreign investors.
Does not include value of 5-year warrant to purchase 217,391 shares of common stock at $0.23 per share. Reasonable expenses may also be paid.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Roth Capital Partners, LLC | 15407 | Roth Capital Partners, LLC · CRD 15407 |
Source: Form D, filed Jun 18, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Arie S. Belldegrun, M.D. | Director |
| Craig W. Carlson | Executive |
| Steven R. Deitcher, M.D. | Director, Executive |
| Nishan De Silva | Director |
| Andrew Ferrer | Director |
| Howard P. Furst, M.D. | Director |
| Anne E. Hagey | Executive |
| Anne E. Hagey, M.D. | Executive |
| John P. Iparraguirre | Executive |
| Jonathan Leff | Director |
| Paul V. Maier | Director |
| Tyler M. Nielsen | Executive |
| Leon E. Rosenberg, M.D. | Director |
| Michael Weiser, M.D. | Director |
| Linda E. Wiesinger | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7000 Shoreline Court Suite 370
South San Francisco, CA, 94080
South San Francisco, CA, 94080